Dopamine Hydrochloride Injection
Brand names: Dopamine Hydrochloride, Dopamine Hydrochloride And Dextrose, Dopamine Hydrochloride In Dextrose
Category: Cardiovascular
FDA status: Current · Last FDA update: Sep 22, 2026 · First posted: Nov 6, 2017 (in shortage 8 years 10 months) · 3 manufacturers, 11 listed presentations
As of Sep 22, 2026, the FDA lists Dopamine Hydrochloride Injection as currently in shortage. Of 11 manufacturer presentations, 3 Unavailable, 8 Available.
| Presentation & package NDC | Manufacturer | Availability | FDA note |
|---|---|---|---|
| Dopamine Hydrochloride, Injection, 40 mg/1 mL (NDC 0143-9252-25) NDC 0143-9252-25 |
Hikma Pharmaceuticals USA, Inc. | Unavailable | Product temporarily on backorder. Additional lots will be available in the February 2027 timeframe. |
| Dopamine Hydrochloride, Injection, 40 mg/1 mL (NDC 0143-9254-25) NDC 0143-9254-25 |
Hikma Pharmaceuticals USA, Inc. | Unavailable | Additional lots will be available in the October 2026 timeframe. Product will be made available as it is released. |
| Dopamine Hydrochloride In Dextrose 5% In Plastic Container, Injection, 80 mg/100 mL (NDC 0338-1005-03) NDC 0338-1005-03 |
Baxter Healthcare | Available | - |
| Dopamine Hydrochloride In Dextrose 5% In Plastic Container, Injection, 80 mg/100 mL (NDC 0338-1005-02) NDC 0338-1005-02 |
Baxter Healthcare | Available | - |
| Dopamine Hydrochloride In Dextrose 5% In Plastic Container, Injection, 160 mg/100 mL (NDC 0338-1007-02) NDC 0338-1007-02 |
Baxter Healthcare | Available | - |
| Dopamine Hydrochloride In Dextrose 5% In Plastic Container, Injection, 160 mg/100 mL (NDC 0338-1007-03) NDC 0338-1007-03 |
Baxter Healthcare | Available | - |
| Dopamine Hydrochloride In Dextrose 5% In Plastic Container, Injection, 400 mg/250 mL (1.6 mg/1 mL) (NDC 0409-0042-12) NDC 0409-0042-12 |
Hospira, Inc., a Pfizer Company | Available | - |
| Dopamine Hydrochloride In Dextrose 5% In Plastic Container, Injection, 800 mg/250 mL (3.2 mg/1 mL) (NDC 0409-1858-12) NDC 0409-1858-12 |
Hospira, Inc., a Pfizer Company | Available | - |
| Dopamine Hydrochloride In Dextrose 5% In Plastic Container, Injection, 800 mg/500 mL (1.6 mg/1 mL) (NDC 0409-7809-24) NDC 0409-7809-24 |
Hospira, Inc., a Pfizer Company | Unavailable | Next Delivery and Estimated Recovery: December 2027; Shortage per Manufacturer: Manufacturing Delay |
| Dopamine Hydrochloride, Injection, 200 mg/5mL (40 mg/1 mL) (NDC 0409-5820-01) NDC 0409-5820-01 |
Hospira, Inc., a Pfizer Company | Available | - |
| Dopamine Hydrochloride, Injection, 400 mg/10mL (40 mg/1 mL) (NDC 0409-9104-20) NDC 0409-9104-20 |
Hospira, Inc., a Pfizer Company | Available | - |
Related medications in shortage
Other Cardiovascular medications currently on the FDA shortage list — useful context if you and your prescriber are weighing alternatives. Always confirm with your pharmacist.
Change log
Tracking began Oct 1, 2026. We check the FDA every 6 hours; any real change - a manufacturer moving from Limited to Available, a new recovery date, a new listing - shows up here with its date.
Cite this: “FDA drug-shortage status for Dopamine Hydrochloride Injection (FDA data as of Sep 22, 2026). Shortage Watch, openFDA.”
Get an email when this record changes
One email, only when the FDA changes something for Dopamine Hydrochloride Injection. You confirm by clicking a link first (double opt-in). No newsletter, no other mail.
Feeds instead of email: RSS or JSON. Unsubscribe anytime; see Privacy.
Embed a live status badge: /badge/dopamine-hydrochloride-injection.svg
FDA data last synced Oct 1, 2026 (FDA record dated Sep 30, 2026).